The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in
TMJ arthralgia. The main questions it aims to answer are:
- How does pain reduction compare?
- How does improvement in jaw function limitation compare?
- How do side effects compare? Participants will
- On day 1 be examined and report their pain level and jaw function limitation
- On days 1-21, apply their cream four times a day
- On day 21, report their pain level, jaw function limitation, compliance with
instructions, and side effects.
Researchers will compare topical 2.5% hydrocortisone and topical 1% diclofenac to see if
efficacy and side effects differ.